VAERS Explorer
Back to explore

Report #2858375

Received Sep 12, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS2UNK—

Symptoms (1)

Injection site vesicles

Symptom narrative

blisters in a circle around my right arm where the patient had the vaccine given both times; This non-serious case was reported by a nurse via other manufacturer and described the occurrence of injection site blisters in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Covid-19 vaccine (vaccine received on an unknown date), Rosuvastatin (received 5 milligrams of Rosuvastatin daily) and Shingrix (1st dose received in December 2019). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced injection site blisters (Verbatim: blisters in a circle around my right arm where the patient had the vaccine given both times). The outcome of the injection site blisters was not reported. It was unknown if the reporter considered the injection site blisters to be related to Shingrix. It was unknown if the company considered the injection site blisters to be related to Shingrix. Linked case(s) involving the same patient: US2025AMR110480 Additional Information: GSK receipt date: 26-AUG-2025 The patient took the second shot and had blisters in a circle around the right arm which is where the patient had the vaccine given both times.